Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial
We describe the protocol for a clinical trial design evaluating the effects ofCinnamomum zeylanicum (Ceylon cinnamon) in patients with type-2 diabetes mellitus. The result of the present study, positive or negative, should provide a step change in the evidence guiding current and future policies regarding the use of cinnamon dietary supplementation in patients with diabetes.Trial registrationSri Lanka Clinical Trials Registry (SLCTR), identifier: SLCTR/2017/010 (http://slctr.lk/trials/714). Registered on 5 April 2017; study protocol version 3.1 21 March 2017. (Source: Trials)
Source: Trials - September 29, 2017 Category: Research Source Type: clinical trials

Effects of Cinnamon Supplementation on Glucose Metabolism in Patients With Pre-diabetes
Conditions:   Dysglycemia;   Obesity Interventions:   Dietary Supplement: Cinnamon;   Other: placebo Sponsors:   Joslin Diabetes Center;   Kyunghee University Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2017 Category: Research Source Type: clinical trials